EditCo, Promega to Combine CRISPR Knock-In Capabilities with Protein-Labeling Tech

EditCo Bio secures access to Promega’s technologies in new deal

EditCo Bio has entered a licensing agreement to secure access to Promega’s protein-tagging and bioluminescent identification technologies.

EditCo, Promega to Combine CRISPR Knock-In Capabilities with Protein-Labeling Tech

EditCo Bio and Promega have announced a strategic licensing agreement that grants EditCo access to Promega’s HiBiT, HaloTag, and NanoLuc technologies. Under the terms of the arrangement, EditCo will incorporate Promega’s bioluminescent and protein-labeling technologies into its CRISPR-engineered cell lines. According to the partners, the combined solutions will allow customers to generate precise gene edits in cell lines with functional validati…